newsfilter
← Latest News
PR Newswire·

Medivir partner Infex Therapeutics receives FDA QIDP designation

STOCKHOLM, Jan. 11, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) announced today that its partner Infex Therapeutics, a leading anti-infectives specialist, has been granted Qualified Infectious Disease